Anti-CD19 (Coltuximab)-SPDB-DM4 ADC
This ADC product is comprised of an anti-CD19 monoclonal antibody conjugated via a SPDB linker to DM4. The DM4 is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, DM1 binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1050621-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus (strain N315) Gamma-hemolysin component B
Sign In for Pricing
View Details MBS1050621-02 0.02 mg (Yeast)
Recombinant Staphylococcus aureus (strain N315) Gamma-hemolysin component B
Sign In for Pricing
View Details 
MBS1050621-03 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus (strain N315) Gamma-hemolysin component B
Sign In for Pricing
View Details 
MBS1050621-04 0.1 mg (Yeast)
Recombinant Staphylococcus aureus (strain N315) Gamma-hemolysin component B
Sign In for Pricing
View Details MBS1050621-05 1 mg (E-Coli)
Recombinant Staphylococcus aureus (strain N315) Gamma-hemolysin component B
Sign In for Pricing
View Details